Multi-center prospective survey of hepatocellular carcinoma in Kerala: More than 1,200 cases
Authors:
- 1 April 2023
- journal article
- research article
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 42 (2) , 233-240
Abstract
Background Hepatocellular carcinoma (HCC) is considered uncommon in India. The aim of this study was to document the demographic characteristics and clinical aspects of HCC in Kerala, India. Methods A survey of HCC in Kerala was performed. All gastroenterologists in the region were invited. From May 2018 to April 2020, data was collected in a standardized questionnaire. Results Forty-three doctors from 15 centers contributed the data. Total 1217 patients were analyzed. This is the largest state-wide survey of HCC in India. HCC was more common in men (90%) than in women (p < 0.01). The etiology of liver disease was hepatitis B virus (7%), hepatitis C virus (4%) and alcohol (40%). Diabetes mellitus was present in 64%, hypercholesterolemia in 17% and hypertension in 38%. Obesity was present in 33% and 15% were overweight. Non-alcoholic fatty liver disease (NAFLD) with or without metabolic syndrome was present in 44%. Serum alpha-fetoprotein was > 400 ng/mL in 24%, total tumor diameter was > 5 cm in 59%, portal vein invasion was seen in 35% and distant metastasis was seen in 15%. Specific therapy was given to 52%. Treatments given included liver transplantation (n = 24), liver resection (n = 39) and transarterial chemoembolization (TACE, n = 184). Although the study was not designed to compare survival, patients who had liver transplantation had longer survival (median 69 months) compared to matched patients given only TACE (median 18 months) (p = 0.03). Conclusion HCC is common in Kerala, India. NAFLD has a predominant association with HCC in Kerala. Most of the patients report late when curative treatment is not possible.Keywords
This publication has 18 references indexed in Scilit:
- Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting—A Retrospective Descriptive AnalysisJournal of Clinical and Experimental Hepatology, 2021
- 2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II RecommendationsJournal of Clinical and Experimental Hepatology, 2020
- International trends in hepatocellular carcinoma incidence, 1978–2012International Journal of Cancer, 2019
- Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data SystemJournal of Clinical and Experimental Hepatology, 2019
- Patients with Barcelona Clinic Liver Cancer Stages B and C Hepatocellular Carcinoma: Time for a SubclassificationLiver Cancer, 2018
- Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in IndiaIndian Journal of Gastroenterology, 2017
- Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern IndiaIndian Journal of Gastroenterology, 2013
- Hepatocellular carcinoma continues to be diagnosed in the advanced stage: profile of hepatocellular carcinoma in a tertiary care hospital in South IndiaTropical Doctor, 2013
- Clinical Profile, Etiology and Therapeutic Outcome in 324 Hepatocellular Carcinoma Patients at a Tertiary Care Center in IndiaOncology, 2009
- Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 casesQJM: An International Journal of Medicine, 2008